tirzepatide fda approval 2022 The long awaited twincretin was just approved on Friday for type 2 diabetes! π Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP F.D.A. Approves New Obesity Drug
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 9 - Aug 14



























